Skip to Content

Penicillin v potassium Pregnancy and Breastfeeding Warnings

Penicillin v potassium is also known as: A-Cillin, Beepen-VK, Ledercillin VK, PC Pen VK, Pen-V, Pen-Vee K, Penicillin VK, Truxcillin VK, V-Cillin K, Veetids

Penicillin v potassium Pregnancy Warnings

Animal studies have failed to reveal evidence of fetal harm. This drug crosses the placenta. No positive evidence of adverse effects on the fetus observed during human use of penicillins; however, there are no controlled data in human pregnancy. AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed; it has been used without apparent harmful effects. Caution is recommended. AU TGA pregnancy category: A US FDA pregnancy category: B

See references

Penicillin v potassium Breastfeeding Warnings

According to limited data, single maternal doses of 1320 mg produce low levels in breast milk. In 16 women, milk drug levels were measured after a single 1320 mg oral dose. In 7 women with mastitis, peak milk levels averaged 0.72 mg/L in the breast with mastitis and 0.58 mg/L in the unaffected breast; peak levels occurred 2.6 to 2.7 hours after dosing. In 4 controls (women without mastitis), peak milk levels averaged 0.3 mg/L at 5.4 hours after dosing. Differences in mastitic milk levels and control milk levels were statistically significantly from nonmastitic milk levels in the women with mastitis in the opposite breast. The average milk level and AUC were greater in the women with mastitis (not statistically significant). According to author estimation, an exclusively breastfed infant would receive about 50 mcg/kg/day (range: 20 to 90 mcg/kg/day). Nursing mothers were given a single 1320 mg oral dose. At 2 hours after nursing, urine drug level was measured in 2 of the breastfed infants; urine level was undetectable in 1 infant and 520 mcg/L in the other infant. In 1 study, 12 infants were breastfed during maternal use of this drug. No effects were observed in 7 infants (appeared normal), looser stools than normal occurred in 3 infants, and a rash developed on the buttocks of 1 infant on the last day of therapy; such effects were possibly related to penicillin V in milk, but there was no control group. Stains of blood were seen in the stool of 1 infant, but this had occurred one time before the mother used this drug.

Use is considered acceptable; caution is recommended. -According to some authorities, this drug should not be used unless the benefit outweighs the risk. Excreted into human milk: Yes Comments: -Low levels in milk are not expected to cause harmful effects in the nursing infant. -Disruption of infant's gastrointestinal flora (resulting in diarrhea or thrush) reported occasionally with penicillins, but such effects have not been adequately evaluated; possibility of allergy/sensitization should be considered.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm." ([2014, Nov -]):
  4. "Product Information. Veetids (penicillin)." Apothecon Inc, Plainsboro, NJ.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. "Product Information. Veetids (penicillin)." Apothecon Inc, Plainsboro, NJ.
  3. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm." ([2014, Nov -]):
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  5. Cerner Multum, Inc. "Australian Product Information." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide